Physician profile
Alejandra Martinez
NPI 1548832983
$1,494.08
in general payments reported to CMS, 2019-2025
11 companies · $922 in 2025
The $922 reported for 2025 was more than what 84% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.65 · 2022: $29.18 · 2023: $33.67 · 2024: $484 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $725.07 | 2025 | Korlym |
| Shockwave Medical, INC | $417.35 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbvie INC. | $108.32 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $73.67 | 2023-2025 | Brilinta, Tagrisso |
| Novartis Pharmaceuticals Corporation | $41.79 | 2021-2022 | |
| Beta Bionics, INC. | $28.77 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ascensia Diabetes Care US INC. | $23.97 | 2025 | |
| Novo Nordisk INC | $21.72 | 2025 | Ozempic |
| Pfizer INC. | $20.98 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $20.40 | 2023 | Eliquis |
| Teleflex LLC | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandra Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.